U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H35NO
Molecular Weight 353.5408
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAURDAN

SMILES

CCCCCCCCCCCC(=O)C1=CC2=C(C=C1)C=C(C=C2)N(C)C

InChI

InChIKey=JHDGGIDITFLRJY-UHFFFAOYSA-N
InChI=1S/C24H35NO/c1-4-5-6-7-8-9-10-11-12-13-24(26)22-15-14-21-19-23(25(2)3)17-16-20(21)18-22/h14-19H,4-13H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C24H35NO
Molecular Weight 353.5408
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Distinct behaviour of the homeodomain derived cell penetrating peptide penetratin in interaction with different phospholipids.
2010-12-30
Numerical studies of the membrane fluorescent dyes dynamics in ground and excited states.
2010-09
Fluorescence imaging of membrane dynamics in living cells.
2010-08-31
Light dose is a limiting factor to maintain cell viability in fluorescence microscopy and single molecule detection.
2010-03-08
Quantification of protein-lipid selectivity using FRET.
2010-03
Biophysical effects of the natural product euplotin C on the Paramecium membrane.
2009-11
Thermo-sensitive response based on the membrane fluidity adaptation in Paramecium multimicronucleatum.
2009-09-01
Properties of mixed cationic membranes studied by fluorescence solvent relaxation.
2008-09
Fluorescence study of the solvation of fluorescent probes prodan and laurdan in poly(epsilon-caprolactone)-block-poly(ethylene oxide) vesicles in aqueous solutions with tetrahydrofurane.
2008-01-01
Laurdan fluorescence spectroscopy in the thylakoid bilayer: the effect of violaxanthin to zeaxanthin conversion on the galactolipid dominated lipid environment.
2008-01
Critical factors for detection of biphasic changes in membrane properties at specific sterol mole fractions for maximal superlattice formation.
2007-05-17
A two-photon fluorescent probe for lipid raft imaging: C-laurdan.
2007-03-26
Fluorescence detection of signs of sterol superlattice formation in lipid membranes.
2007
Correlation between thermotolerance and membrane properties in Paramecium aurelia.
2006-09
Laurdan in fluid bilayers: position and structural sensitivity.
2006-05
Binding of alpha-synuclein affects the lipid packing in bilayers of small vesicles.
2006-04-07
Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to ceramide.
2006-02
Glycolipid transfer protein interaction with bilayer vesicles: modulation by changing lipid composition.
2005-12
Pressure-induced phase transitions of lipid bilayers observed by fluorescent probes Prodan and Laurdan.
2005-10-03
On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity.
2005-09
Pressure-induced shape change of phospholipid vesicles: implication of compression and phase transition.
2005-04
Phase transition affects energy transfer efficiency in phospholipid vesicles.
2005-04
Visualization and analysis of apolipoprotein A-I interaction with binary phospholipid bilayers.
2005-04
Hemolysis of erythrocytes and erythrocyte membrane fluidity changes by new lysosomotropic compounds.
2005-03
Chemical-physical properties of lipoproteins in anorexia nervosa.
2004-11
Different modulation of phospholipase A2 activity by saturated and monounsaturated N-acylethanolamines.
2003-04
Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules.
2003-02
Direct observation of lipid domains in free standing bilayers: from simple to complex lipid mixtures.
2003-01
Activation of dynamin II by POPC in giant unilamellar vesicles: a two-photon fluorescence microscopy study.
2002-08
Phototoxic effect of fluoroquinolones on two human cell lines.
2002-08
Segregation of saturated chain lipids in pulmonary surfactant films and bilayers.
2002-04
Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins.
2002-01
Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-).
2001-07-01
Tamoxifen perturbs lipid bilayer order and permeability: comparison of DSC, fluorescence anisotropy, laurdan generalized polarization and carboxyfluorescein leakage studies.
2001-04-10
Surface properties of cholesterol-containing membranes detected by Prodan fluorescence.
2001-04-02
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:43:59 GMT 2025
Edited
by admin
on Mon Mar 31 19:43:59 GMT 2025
Record UNII
Y97FBL93VW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-DODECANONE, 1-(6-(DIMETHYLAMINO)-2-NAPHTHALENYL)-
Preferred Name English
LAURDAN
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID80225517
Created by admin on Mon Mar 31 19:43:59 GMT 2025 , Edited by admin on Mon Mar 31 19:43:59 GMT 2025
PRIMARY
WIKIPEDIA
Laurdan
Created by admin on Mon Mar 31 19:43:59 GMT 2025 , Edited by admin on Mon Mar 31 19:43:59 GMT 2025
PRIMARY
CAS
74515-25-6
Created by admin on Mon Mar 31 19:43:59 GMT 2025 , Edited by admin on Mon Mar 31 19:43:59 GMT 2025
PRIMARY
FDA UNII
Y97FBL93VW
Created by admin on Mon Mar 31 19:43:59 GMT 2025 , Edited by admin on Mon Mar 31 19:43:59 GMT 2025
PRIMARY
PUBCHEM
104983
Created by admin on Mon Mar 31 19:43:59 GMT 2025 , Edited by admin on Mon Mar 31 19:43:59 GMT 2025
PRIMARY